CompletedNot Applicable

Platelet Inhibition and Bleeding in Patients Undergoing Emergent Cardiac Surgery

Austria167 participantsStarted 2011-01

Plain-language summary

The aim of the study is to evaluate if there is an association between platelet inhibition and surgery-related bleeding in patients undergoing emergent cardiac surgery during dual antiplatelet therapy.

Who can participate

Age range30 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * First time on-pump CABG with or without valve replacement Exclusion Criteria: * Redo surgery, * Renal insufficiency needing dialysis, * Concomitant medication with warfarin, * Preoperative fibrinogen \< 150 mg%

What they're measuring

Calculated Blood Loss

Timeframe: until postoperative day 5

Trial details

NCT IDNCT01468597

SponsorMedical University of Graz

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-08

Results submitted2020-03-09

View on ClinicalTrials.gov More Bleeding trials